ROS-activated SHP-1 signaling underlies artesunate-mediated inhibition of EMT and STAT3-Driven prostate cancer progression
Archives of Biochemistry and Biophysics · 2026
DOI: 10.1016/j.abb.2026.111003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2026. Verfasst von Young Yun Jung und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Science in Korean Medicine, Kyung Hee University, 24 Kyungheedae-ro, Dongdaemun-gu, Seoul, 02447, Republic of Korea. Hauptthemen laut MEDLINE: Prostatic Neoplasms, STAT3 Transcription Factor, Reactive Oxygen Species, Artesunate. Die Arbeit nennt 40 Literaturangaben. Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Constitutive activation of signal transducer and activator of transcription 3 (STAT3) is a hallmark of prostate cancer (PC) progression. Here, we investigated the anticancer effects of artesunate (ART) and its underlying mechanisms in PC. ART selectively reduced the viability of PC cells with minimal toxicity toward normal prostate cells by inducing apoptosis, as evidenced by increased sub-G1 accumulation, Annexin V/propidium iodide (PI)-positive cells, and DNA fragmentation. These effects were mediated by reactive oxygen species (ROS), as glutathione (GSH) and N-acetyl-l-cysteine (NAC) significantly reversed ART-induced cytotoxicity. ART also depleted intracellular GSH and reduced superoxide dismutase (SOD) expression, thereby enhancing oxidative stress. Inhibition of STAT3 by ART was reversed by sodium orthovanadate, implicating protein tyrosine phosphatases (PTPs) in this process. ART downregulated anti-apoptotic B-cell lymphoma-2 (Bcl-2) family proteins, suppressed C-X-C motif chemokine ligand 12 (CXCL12)-induced migration, and inhibited epithelial-mesenchymal transition (EMT) through ROS-dependent activation of Src homology region 2 domain-containing phosphatase-1 (SHP-1). In vivo, ART significantly inhibited prostate tumor xenograft growth, reduced oncogenic protein expression in tumors, and lowered serum interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) levels. Collectively, ART suppresses PC growth, survival, migration, and EMT by targeting the STAT3 and ROS/SHP-1 signaling pathways, supporting its potential as a therapeutic candidate for PC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Science in Korean Medicine, Kyung Hee University, 24 Kyungheedae-ro, Dongdaemun-gu, Seoul, 02447, Republic of Korea.
- Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, 117600, Singapore.
- Department of Molecular Biology, University of Mysore, Manasagangotri, Mysore, Karnataka, 570006, India.
- Division of Cellular and Molecular Research, Humphrey Oei Institute of Cancer Research, National Cancer Centre, 169610, Singapore.
- Institution of Excellence, Vijnana Bhavan, University of Mysore, Manasagangotri, Mysore, 570006, India.
- Department of Science in Korean Medicine, Kyung Hee University, 24 Kyungheedae-ro, Dongdaemun-gu, Seoul, 02447, Republic of Korea; Kyung Hee Institute of Convergence Korean Medicine, Kyung Hee University, 24 Kyungheedae…
Förderung
- National Research Foundation of Korea
Zitieren
APA
Jung, Y. Y., Nachiyappan, A., Kim, N. Y., Mohan, C. D., Bhol, C. S., Shanmugam, M. K., Siveen, K. S., Kumar, A. P., Deivasigamani, A., Rangappa, K. S., Hui, K. M., & Ahn, K. S. (2026). ROS-activated SHP-1 signaling underlies artesunate-mediated inhibition of EMT and STAT3-Driven prostate cancer progression. Archives of Biochemistry and Biophysics. https://doi.org/10.1016/j.abb.2026.111003
Vancouver
Jung YY, Nachiyappan A, Kim NY, Mohan CD, Bhol CS, Shanmugam MK, et al. ROS-activated SHP-1 signaling underlies artesunate-mediated inhibition of EMT and STAT3-Driven prostate cancer progression. Archives of Biochemistry and Biophysics. 2026. doi:10.1016/j.abb.2026.111003
BibTeX
@article{Jung2026,
author = {Jung, Young Yun and Nachiyappan, Alamelu and Kim, Na Young and Mohan, Chakrabhavi Dhananjaya and Bhol, Chandra Sekhar and Shanmugam, Muthu K and Siveen, Kodappully Sivaraman and Kumar, Alan Prem and Deivasigamani, Amudha and Rangappa, Kanchugarakoppal S and Hui, Kam Man and Ahn, Kwang Seok},
title = {ROS-activated SHP-1 signaling underlies artesunate-mediated inhibition of EMT and STAT3-Driven prostate cancer progression},
journal = {Archives of Biochemistry and Biophysics},
year = {2026},
doi = {10.1016/j.abb.2026.111003}
}
EUVIMED